Medicine
Showing 1-10 of 25 Results
-
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.
-
Shreya Gupta
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsI am a biomedical researcher focused on understanding the molecular mechanisms governing vascular smooth muscle cell (SMC) behavior in cardiovascular and metabolic diseases. My work investigates how signaling pathways, including Notch3 and Thrombospondin-1, regulate SMC phenotypic switching, fibrous cap stability, and plaque vulnerability in atherosclerosis, with the goal of identifying novel therapeutic targets to prevent heart attacks and strokes.
-
Jiaqi Hu
Postdoctoral Scholar, Cardiovascular Medicine
BioJiaqi Hu is a Postdoctoral Scholar at Stanford University, supervised by Drs. Tim Assimes and Shoa Clarke. She received her PhD in Chronic Disease Epidemiology from the Yale School of Public Health in 2026 and her Bachelor of Arts degree from Peking University in 2021. Her research focuses on identifying genetic variants underlying complex diseases, applying polygenic scores for disease risk prediction and subtype identification, and integrating genetic, environmental, and clinical data to improve individual-level risk stratification.
